Neurix is a small start-up company from the University of Geneva located in Geneva in the startup park Eclosion. It was started in 2011 by Prof. Karl-Heinz Krause and Prof. Luc Stoppini
According to the Venture summary sheet -pdf (as of 2011), Neurix has a company size of 2.2 FTE (full time equivalents), so it is very much in the startup phase.
They currently have two funded projects listed on their webpage, a CTI grant in collaboration with the University of Geneva, and they are part of an FP7 project. The FP7 project is called NEURINOX and will be used to screen compounds, and the example they give is NOX. One of the partners in this project is Genkyotex Innovation (a French company owned by the Swiss company Genkyotex) which makes the NOX inhibitors for testing and was also started by Prof. Karl-Heinz Krause in 2006.
No comments:
Post a Comment